Open1.700 | Close1.660 |
Vol / Avg.24.484K / 6.409K | Mkt Cap7.157M |
Day Range1.645 - 1.730 | 52 Wk Range1.550 - 4.450 |
Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Open1.700 | Close1.660 |
Vol / Avg.24.484K / 6.409K | Mkt Cap7.157M |
Day Range1.645 - 1.730 | 52 Wk Range1.550 - 4.450 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-06-05 | Ladenburg Thalmann | Aydin Huseynov | Maintains | BuyBuy | Lowers | 20.00 | 10.00 |
2022-08-03 | Ladenburg Thalmann | Aydin Huseynov | Initiates Coverage On | Buy | Announces | - | 2.00 |
2022-06-23 | Goldman Sachs | - | Maintains | Neutral | Lowers | 11.00 | 3.00 |
2021-08-20 | Benchmark | Aydin Huseynov | Initiates Coverage On | Speculative Buy | Announces | - | 4.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ATHE | Alterity Therapeutics | -2.76% | 7.2M |
ALZN | Alzamend Neuro | -5.83% | 7.4M |
IMNN | Imunon | 5.02% | 8.9M |
FNCH | Finch Therapeutics Gr | 2.86% | 6.9M |
GRTX | Galera Therapeutics | 0.77% | 7.8M |
You can purchase shares of Alterity Therapeutics (NASDAQ: ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Imunon (NASDAQ:IMNN), Finch Therapeutics Gr (NASDAQ:FNCH), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Ladenburg Thalmann on Monday, June 5, 2023. The analyst firm set a price target for 10.00 expecting ATHE to rise to within 12 months (a possible 468.18% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.76 last updated November 27, 2023 at 2:28 PM UTC.
There is no dividend information for Alterity Therapeutics.
Alterity Therapeutics’s Q3 earnings are confirmed for Tuesday, January 30, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.